---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-005437"
form_type: "8-K"
ticker: "RNXT"
cik: "0001574094"
company_name: "RenovoRx, Inc."
filed_at: "2026-02-06T23:59:59+00:00"
generated_at: "2026-05-16T04:05:27.005323+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# RenovoRx appoints Mark Voll as CFO; Kocak resigns as Principal Accounting Officer but remains Controller

## Summary
- Mark Voll, age 72, appointed CFO effective Feb 4, 2026; also serves as Principal Financial and Accounting Officer.
- Ronald B. Kocak resigned as Principal Accounting Officer effective Feb 3, 2026; remains VP and Controller with same salary.
- Voll receives $250/hour (50% cash, 50% RSUs) plus initial grant of 60,000 unvested RSUs under 2021 Omnibus Plan.
- Voll brings 30+ years finance/accounting experience; led IPOs at Techwell, Montage, Aquantia.
- Company generated ~$900K revenue from RenovoCath sales in first nine months of 2025; repeat orders growing.

## SEC filing metadata
- accession: 0001493152-26-005437
- form_type: 8-K
- ticker: RNXT
- cik: 0001574094
- company_name: RenovoRx, Inc.
- filed_at: 2026-02-06T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1574094/000149315226005437/0001493152-26-005437-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1574094/000149315226005437/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-005437
- JSON: https://secwatch.observer/filing/0001493152-26-005437.json
- Plain text: https://secwatch.observer/filing/0001493152-26-005437.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.